Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae

被引:104
作者
Ren, B
Szalai, AJ
Thomas, O
Hollingshead, SK
Briles, DE
机构
[1] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
关键词
D O I
10.1128/IAI.71.1.75-85.2003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pneumococcal surface protein A (PspA), a virulence factor of Streptococcus pneumoniae, is exceptionally diverse, being classified into two major families which are over 50% divergent by sequence analysis. A family I PspA from strain WU2 was previously shown to impede the clearance of pneumococci from mouse blood and to interfere with complement deposition on the bacterial surface. To determine whether a family 2 PspA can perform the same role as family 1 PspA, the family 1 PspA (from strain WU2) was replaced with a family 2 PspA (from strain TIGR4) by molecular genetic methods to make an isogenic pair of strains expressing different PspA proteins. Surface binding of lactoferrin and interference with C3 deposition by the two types of PspA proteins were determined by flow cytometry, and virulence was assessed in a mouse bacteremia model. Although the family 2 PspA appeared to bind less human lactoferrin than did the family 1 PspA, both PspA proteins could interfere with complement deposition on the pneumococcal surface and could provide full virulence in the mouse infection model. A mutant form of the family 2 PspA with a deletion within the choline-binding region was also produced. Pneumococci with this mutant PspA failed to bind human lactoferrin even though the PspA was present on the pneumococclal surface. The mutant PspA only partially interfered with complement deposition and moderately attenuated virulence. These results suggest that family 1 and family 2 PspA proteins play similar roles in virulence and that surface accessibility of PspA is important for their function.
引用
收藏
页码:75 / 85
页数:11
相关论文
共 36 条
[1]  
ABEYTA M, 1999, THESIS U ALABAMA BIR
[2]   BACTERICIDAL EFFECT FOR HUMAN LACTOFERRIN [J].
ARNOLD, RR ;
COLE, MF ;
MCGHEE, JR .
SCIENCE, 1977, 197 (4300) :263-265
[3]   PspA and PspC: Their potential for use as pneumococcal vaccines [J].
Briles, DE ;
Hollingshead, SK ;
Swiatlo, E ;
Brooks-Walter, A ;
Szalai, A ;
Virolainen, A ;
McDaniel, LS ;
Benton, KA ;
White, P ;
Prellner, K ;
Hermansson, A ;
Aerts, PC ;
Van Dijk, H ;
Crain, MJ .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1997, 3 (04) :401-408
[4]  
BRILES DE, 1988, REV INFECT DIS, V10, pS372
[5]  
Brooks-Walter A, 1999, INFECT IMMUN, V67, P6533
[6]   Novel purification scheme and functions for a C3-binding protein from Streptococcus pneumoniae [J].
Cheng, Q ;
Finkel, D ;
Hostetter, MK .
BIOCHEMISTRY, 2000, 39 (18) :5450-5457
[7]  
Coral MCV, 2001, EMERG INFECT DIS, V7, P832
[8]   PNEUMOCOCCAL SURFACE PROTEIN-A (PSPA) IS SEROLOGICALLY HIGHLY VARIABLE AND IS EXPRESSED BY ALL CLINICALLY IMPORTANT CAPSULAR SEROTYPES OF STREPTOCOCCUS-PNEUMONIAE [J].
CRAIN, MJ ;
WALTMAN, WD ;
TURNER, JS ;
YOTHER, J ;
TALKINGTON, DF ;
MCDANIEL, LS ;
GRAY, BM ;
BRILES, DE .
INFECTION AND IMMUNITY, 1990, 58 (10) :3293-3299
[9]   Surface expression of lactoferrin by resting neutrophils [J].
Deriy, LV ;
Chor, J ;
Thomas, LL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 275 (01) :241-246
[10]   Role of novel choline binding proteins in virulence of Streptococcus pneumoniae [J].
Gosink, KK ;
Mann, ER ;
Guglielmo, C ;
Tuomanen, EI ;
Masure, HR .
INFECTION AND IMMUNITY, 2000, 68 (10) :5690-5695